Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: GE Healthcare; BioServe; DNA Genotek

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GE Healthcare has opened a new medical technology manufacturing facility in Cardiff, Wales. The $15 million facility will produce nearly 2,000 life sciences products used in the pharmaceutical, food, and environmental industries. GE said that it already employs more than 400 people at the facility.

BioServe said this week that it has received accreditation from India's National Board of Testing and Calibration of Laboratories for detecting genetically modified materials in raw and processed foods. The firm announced the accreditation in conjunction with the launch of a line of PCR-based tests for detecting genetically modified organisms.

DNA Genotek said that the South African Tuberculosis Vaccine Initiative has chosen to use the firm's Oragene DNA Self-Collection Kits to obtain samples for a study aimed at identifying host correlates of protection against TB, following BCG vaccination.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.